BLACKROCK ADVISORS LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 41 filers reported holding IMMUNE DESIGN CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 3.5%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$368,000
-22.5%
66,849
+6.7%
0.00%
Q3 2016$475,000
-3.5%
62,673
+3.8%
0.00%
Q2 2016$492,000
-37.3%
60,3550.0%0.00%
-100.0%
Q1 2016$785,000
-35.3%
60,355
-0.1%
0.00%0.0%
Q4 2015$1,213,000
+59.6%
60,413
-3.0%
0.00%0.0%
Q3 2015$760,000
-76.7%
62,282
-60.6%
0.00%
-66.7%
Q2 2015$3,263,000
+130.6%
158,011
+135.7%
0.00%
+200.0%
Q1 2015$1,415,000
+502.1%
67,039
+777.6%
0.00%
Q4 2014$235,000
+487.5%
7,639
+237.7%
0.00%
Q3 2014$40,0002,2620.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2014
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$97,072,000100.00%
ProQuest Associates IV LLC 2,695,757$82,975,00042.05%
Cormorant Asset Management, LP 140,000$4,309,0000.66%
HAMILTON LANE ADVISORS LLC 42,812$1,318,0000.50%
Spark Investment Management LLC 16,300$498,0000.08%
RS INVESTMENT MANAGEMENT CO LLC 299,102$9,206,0000.08%
Focused Wealth Management, Inc 1,634$50,0000.04%
SECTORAL ASSET MANAGEMENT INC 21,181$652,0000.03%
Numeric Investors LLC 37,012$1,139,0000.02%
FRANKLIN RESOURCES INC 738,026$22,716,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders